by Karolinska Institutet The antidepressant fluoxetine has been suggested as a means to improve brain recovery after acute stroke. However, a large randomized study on stroke patients at 35 Swedish hospitals shows that the drug has no such effect. The study, which was led by researchers at Karolinska Institutet, is published in The Lancet Neurology....
by University of Virginia Doctors can examine COVID-19 patients’ blood to identify those at greatest risk of severe illness and to pinpoint those most likely to need a ventilator, new research from the University of Virginia School of Medicine suggests. The discovery could lead to new treatments to prevent deadly “cytokine storms” seen in severe...
(HealthDay)—Long-term antidepressant use increases the risk for type 2 diabetes onset in a time- and dose-dependent manner, according to a study published online Feb. 12 in Diabetes Care. Hiroyuki Miidera, from the National Institute of Mental Health in Tokyo, and colleagues evaluated associations between the risk for new-onset type 2 diabetes mellitus and the duration...
by American Osteopathic Association Researchers provide a schedule for gradually reducing dosage for each class and type of antidepressant, along with associated withdrawal symptoms for which patients and physicians should monitor. Credit: JAOA Patients who have taken antidepressants for years should consider coming off the medication. However, researchers say they will likely face difficult and...
A new method of interpreting brain activity could be used in clinics to help determine the best treatment options for depression, according to a Stanford-led trial. Stanford researchers and their collaborators used electroencephalography, a tool for monitoring electrical activity in the brain, and an algorithm to identify a brain-wave signature in individuals with depression who...
Home Archive October 2019 Bio Business Antidepressant Approvals Could Herald New Era in Psychiatric Drugs The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development. Oct 1, 2019 BIANCA NOGRADY 1K ABOVE: © ISTOCK.COM, MARTIN BARRAUD As droughts go, the one plaguing...
by Judy George, Senior Staff Writer, MedPage Today August 20, 2019 Dual antiplatelet therapy should be started within 24 to 48 hours of high-risk transient ischemic attack (TIA) or minor ischemic stroke and continued for 21 days, a pooled analysis of the CHANCE and POINTtrials found. Clopidogrel-aspirin treatment started quickly reduced the risk of major...
by Journal of Psychotherapy and Psychosomatics A new study indicates that the antidepressant effects of ketamine may not be such, according to a paper published in Psychotherapy and Psychosomatics. The study investigates the hypothesis that depressed individual receiving ketamine infusions, associate feelings of lightness and floating which are a typical occurrence in the use of...
Marketed and prescribed for a variety of muscle and nerve conditions, compounded topical pain creams and gels work about as well as placebos, study shows JOHNS HOPKINS MEDICINE In an effort to reduce chronic pain, many people look for hope by paying $20 to thousands of dollars for a tube of prescription topical pain cream or gel. Now, results of...
For the first time in decades, researchers have identified a new medication that can successfully treat major depression. Depression affects about 300 million people across the globe, making the condition the “leading cause of ill health and disability worldwide,” according to the World Health Organization (WHO). Image: An existing oral drug may relieve major depression. In 2016 in the United States, over...
